PMCID	SENTENCE_NUMBER	SENTENCE	SENTENCE_INDICES	ONTOLOGY_CONCEPT_IDS_LIST
16504174	0	['Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5)\n\nAbstract\n\nBackground\n\nEmbryonic stem cell-specific gene (ESG) 1, which encodes a KH-domain containing protein, is specifically expressed in early embryos, germ cells, and embryonic stem (ES) cells.']	(0, 288)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0000586', 'CL:0000586', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'GO:0010467', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0000704', 'SO:0000704', 'SO:0000417', 'UBERON:0000922', 'UBERON:0019248', 'UBERON:0019248', 'UBERON:0000922']
16504174	1	['Previous studies identified genomic clones containing the mouse ESG1 gene and five pseudogenes.']	(289, 384)	['NCBITaxon:10088', 'PR:000006847', 'SO:0000040', 'SO:0000040', 'SO:0000704', 'SO:0000336']
16504174	2	['However, their chromosomal localizations or physiological functions have not been determined.']	(385, 478)	[]
16504174	3	['Results\n\nA Blast search of mouse genomic databases failed to locate the ESG1 gene.']	(480, 562)	['NCBITaxon:10088', 'PR:000006847', 'SO:0001026', 'SO:0000704']
16504174	4	['We identified several bacterial artificial clones containing the mouse ESG1 gene and an additional ESG1-like sequence with a similar gene structure from chromosome 9.']	(563, 729)	['NCBITaxon:2', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'SO:0000704', 'SO:0000704']
16504174	5	['The ESG1-like sequence contained a multiple critical mutations, indicating that it was a duplicated pseudogene.']	(730, 841)	['PR:000006847', 'SO:0000336']
16504174	6	["The 5' flanking region of the ESG1 gene, but not that of the pseudogene, exhibited strong enhancer and promoter activity in undifferentiated ES cells by luciferase reporter assay."]	(842, 1021)	['CL:0002322', 'CL:0002322', 'PR:000006847', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0000704', 'SO:0000336', 'SO:0000165', 'SO:0000167']
16504174	7	['To study the physiological functions of the ESG1 gene, we replaced this sequence in ES cells with a β-geo cassette by homologous recombination.']	(1022, 1165)	['CL:0002322', 'CL:0002322', 'PR:000006847', 'SO:0000704', 'SO:0005853']
16504174	8	['Despite specific expression in early embryos and germ cells, ESG1-/- mice developed normally and were fertile.']	(1166, 1276)	['CL:0000586', 'CL:0000586', 'GO:0010467', 'NCBITaxon:10088', 'PR:000006847', 'UBERON:0019248', 'UBERON:0019248']
16504174	9	['We also generated ESG1-/- ES cells both by a second independent homologous recombination and directly from blastocysts derived from heterozygous intercrosses.']	(1277, 1435)	['CL:0002322', 'CL:0002322', 'PR:000006847', 'UBERON:0000358']
16504174	10	['Northern blot and western blot analyses confirmed the absence of ESG1 in these cells.']	(1436, 1521)	['PR:000006847']
16504174	11	['These ES cells demonstrated normal morphology, proliferation, and differentiation.']	(1522, 1604)	['CL:0002322', 'CL:0002322', 'GO:0008283']
16504174	12	['Conclusion\n\nThe mouse ESG1 gene, together with a duplicated pseudogene, is located on chromosome 9.']	(1606, 1705)	['NCBITaxon:10088', 'PR:000006847', 'SO:0000704', 'SO:0000336']
16504174	13	['Despite its specific expression in pluripotent cells and germ cells, ESG1 is dispensable for self-renewal of ES cells and establishment of germcells.']	(1706, 1855)	['CL:0000586', 'CL:0000586', 'CL:0002322', 'CL:0002322', 'CL:0000586', 'GO:0010467', 'GO:0017145', 'GO:0017145', 'GO:0017145', 'GO:0017145', 'GO:0017145', 'GO:0007281', 'GO:0007281', 'GO:0007281', 'PR:000006847']
16504174	14	['Background\n\nEmbryonic stem (ES) cells were first derived from the blastocysts of mice in 1981 [1,2] and humans in 1998 [3].']	(1857, 1980)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'NCBITaxon:10088', 'NCBITaxon:9606', 'UBERON:0000922', 'UBERON:0000358']
16504174	15	['ES cells have two important properties: theability to maintain pluripotency, which is the ability to differentiate into a wide variety of cells, and rapid proliferation.']	(1981, 2150)	['CL:0002322', 'CL:0002322', 'GO:0008283']
16504174	16	['These characteristics make mouse ES cells an essential component of gene targeting technology.']	(2151, 2245)	['CL:0002322', 'CL:0002322', 'NCBITaxon:10088', 'SO:0000704']
16504174	17	['These qualitiesalso make human ES cells attractive sources for cell transplantation therapy to treat various diseases, including spinal cord injuries and juvenile diabetes.']	(2246, 2418)	['CL:0002322', 'CL:0002322', 'NCBITaxon:9606', 'UBERON:0002240', 'UBERON:0002240']
16504174	18	['The molecular mechanisms underlying the pluripotency and rapid proliferation of ES cells are currently a major focus of the field of stem cell biology [4-6].']	(2419, 2576)	['CL:0002322', 'CL:0002322', 'CL:0000034', 'CL:0000034', 'GO:0008283', 'GO:0008283', 'GO:0008283']
16504174	19	['To identify molecules essential in ES cells for these properties, several groups have utilized transcriptome analyses to identify genes specifically expressed in ES cells and early embryos.']	(2578, 2767)	['CHEBI:36357', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'GO:0010467', 'SO:0000704', 'UBERON:0019248', 'UBERON:0019248']
16504174	20	['These analyses, including DNA microarray analyses [7] and expressed sequence tag analyses [8-12], identified several common transcripts, including ESG1 that was also designated dppa5 or ECAT2.']	(2768, 2960)	['GO:0010467', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0000345', 'SO:0000345', 'SO:0000345', 'SO:0000673']
16504174	21	['ESG1 was originally identified as a transcript Ph34 that was down-regulated by retinoic acid in embryonic carcinoma cells [13].']	(2962, 3089)	['CHEBI:26536', 'CHEBI:26536', 'CL:0002321', 'CL:0002321', 'PR:000006847', 'PR:000006847', 'SO:0000673', 'UBERON:0000922']
16504174	22	['The expression of this gene was confined in mice to early embryos and germ cells [14].']	(3090, 3176)	['CL:0000586', 'CL:0000586', 'GO:0010467', 'NCBITaxon:10088', 'SO:0000704', 'UBERON:0019248', 'UBERON:0019248']
16504174	23	['It is also expressed in pluripotent cells, including ES cells, embryonic germ cells, and multipotent germline stem cells [15].']	(3177, 3303)	['CL:0002322', 'CL:0002322', 'CL:0002321', 'CL:0000586', 'CL:0000586', 'CL:0002321', 'CL:0000048', 'CL:0000014', 'CL:0000048', 'CL:0000014', 'CL:0000048', 'CL:0000014', 'GO:0010467', 'UBERON:0000922']
16504174	24	['ESG1 encodes a polypeptide of 118 amino acids that contains a single KH domain, which is an RNA-binding domain [16].']	(3304, 3420)	['PR:000006847', 'SO:0000417', 'SO:0000417']
16504174	25	['It remains unclear, however, if ESG1 functions as an RNA-binding protein or the roles it plays in ES cells and mice.']	(3421, 3537)	['CL:0002322', 'CL:0002322', 'NCBITaxon:10088', 'PR:000006847']
16504174	26	['Previous genomic library screening by identified genomic clones containing the mouse ESG1 gene and seven pseudogenes [17].']	(3539, 3661)	['NCBITaxon:10088', 'PR:000006847', 'SO:0001026', 'SO:0000040', 'SO:0000040', 'SO:0000704', 'SO:0000336']
16504174	27	['Two of these pseudogenes exhibit a similar exon-intron structure as the ESG1 gene, indicating their generation by gene duplication.']	(3662, 3793)	['PR:000006847', 'SO:0000336', 'SO:0000147', 'SO:0000188', 'SO:0000704', 'SO:0000704']
16504174	28	['The five remaining pseudogenes did not contain any introns, indicating that these were generated by retrotransposition of ESG1 transcripts.']	(3794, 3933)	['GO:0032197', 'PR:000006847', 'SO:0000336', 'SO:0000188', 'SO:0000673']
16504174	29	['The chromosomal localizations of the mouse ESG1 gene and pseudogenes, however, have not been reported.']	(3934, 4036)	['NCBITaxon:10088', 'PR:000006847', 'SO:0000704', 'SO:0000336']
16504174	30	['In this study, we determined the structure of the mouse gene encoding this protein and related pseudogenes.']	(4038, 4145)	['NCBITaxon:10088', 'SO:0000704', 'SO:0000336']
16504174	31	['We also performed gene targeting to determine the physiological function of ESG1.']	(4146, 4227)	['PR:000006847', 'SO:0000704']
16504174	32	['Results and discussion\n\nChromosomal localization and structures of mouse ESG1 gene and psedogenes\n\nTo determine the chromosomal localizations of the mouse ESG1 gene and pseudogenes, we performed a Blast analysis of the mouse genomic database with the ESG1 cDNA sequence as a query.']	(4229, 4510)	['NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0000704', 'SO:0000336', 'SO:0000704', 'SO:0000336', 'SO:0001026']
16504174	33	['We identified several putative pseudogenes without introns on chromosomes 1, 5, 11, 12, 14, 16, 17, and X (Figure 1).']	(4511, 4628)	['SO:0000336', 'SO:0000188']
16504174	34	['In addition, two intron-less pseudogenes were identified in DNA fragments for which the chromosomal localization remained unmapped.']	(4629, 4760)	['SO:0000188', 'SO:0000336']
16504174	35	['While these pseudodgenes have significant homology to ESG1 cDNA, they could not produce functional proteins, because of critical mutations.']	(4761, 4900)	['PR:000006847', 'SO:0000336', 'SO:0000857']
16504174	36	['This result suggests that there are a larger number of intron-less pseudogenes than previously anticipated.']	(4901, 5008)	['SO:0000188', 'SO:0000336']
16504174	37	['Existence of multiple retropseudogenes is a hallmark of pluripotent cell-specific genes [18].']	(5009, 5102)	['SO:0000043', 'SO:0000704']
16504174	38	['Figure 1\n\nESG1pseudogenes identified by a Blast search of mouse genomic databases.']	(5104, 5186)	['NCBITaxon:10088', 'PR:000006847', 'SO:0000336', 'SO:0001026']
16504174	39	['Substitution mutations are indicated by black lines.']	(5187, 5239)	[]
16504174	40	['Intron-like gap sequences are indicated with triangles.']	(5240, 5295)	['SO:0000188', 'SO:0000730']
16504174	41	['Chromosomal localizations are shown on the right.']	(5296, 5345)	[]
16504174	42	['On chromosome 9, we identified a DNA fragment similar to the ESG1 gene that included two putative introns.']	(5347, 5453)	['PR:000006847', 'SO:0000704', 'SO:0000188']
16504174	43	['These putative first and second exons, however, contained (4) multiple mutations of the ESG1 cDNA sequence.']	(5454, 5561)	['PR:000006847', 'SO:0000147']
16504174	44	['The putative third exon was identical to that of the previously reported ESG1 gene.']	(5562, 5645)	['PR:000006847', 'SO:0000147', 'SO:0000704']
16504174	45	['Also on chromosome 9, we identified another DNA fragment that was similar, but not identical, to the third exon of the ESG1 gene.']	(5646, 5775)	['PR:000006847', 'SO:0000147', 'SO:0000704']
16504174	46	['These findings suggest that these ESG1-like sequences on chromosome 9 have not been correctly assembled.']	(5776, 5880)	['PR:000006847']
16504174	47	['To obtain DNA fragments containing the ESG1 gene, we screened the bacterial artificial chromosome (BAC) DNA pool by PCR using primer pairs that would only amplify the real gene, not the pseudogenes.']	(5882, 6080)	['NCBITaxon:2', 'PR:000006847', 'SO:0000704', 'SO:0000153', 'SO:0000153', 'SO:0000153', 'SO:0000153', 'SO:0000112', 'SO:0000704', 'SO:0000336']
16504174	48	['We obtained two independent, but overlapping BAC clones.']	(6081, 6137)	['SO:0000153']
16504174	49	['Southern blot analyses and sequencing demonstrated that these clones contained a sequence exhibiting complete identity with ESG1 cDNA that was interrupted by two putative introns (Figure 2A).']	(6138, 6329)	['PR:000006847', 'SO:0000188']
16504174	50	['The two intron sequences begin with GT and terminate with AG, fulfilling the GT-AG rule of exon-intron junctions [19].']	(6330, 6448)	['SO:0000188', 'SO:0001421', 'SO:0001421', 'SO:0001421', 'SO:0001421']
16504174	51	["The 5' flanking region of this DNA fragment exhibited strong promoter/enhancer activity by luciferase reporter assays in undifferentiated ES cells, but not in somatic cells (Figure 3)."]	(6449, 6633)	['CL:0002322', 'CL:0002322', 'CL:0002371', 'CL:0002371', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0000167', 'SO:0000165']
16504174	52	['The same fragment showed much weaker activity after induction of differentiation by retinoic acid.']	(6634, 6732)	['CHEBI:26536', 'CHEBI:26536']
16504174	53	['We concluded that this sequence is the ESG1 gene.']	(6733, 6782)	['PR:000006847', 'SO:0000704']
16504174	54	['Figure 2\n\nBAC clones containing the ESG1 gene and a duplication pseudogene (PS).']	(6784, 6864)	['PR:000006847', 'SO:0000153', 'SO:0000704', 'SO:0000336', 'SO:0000336']
16504174	55	['A) Localization of the gene and PS on chromosome 9.']	(6865, 6916)	['SO:0000704', 'SO:0000336']
16504174	56	['B) Sequence comparison of the gene and PS revealed that these are homologous from eight base pairs upstream of the first exon to 675 bp downstream of the third exon.']	(6917, 7082)	['SO:0000704', 'SO:0000336', 'SO:0000857', 'SO:0000028', 'SO:0000028', 'SO:0000147', 'SO:0000028', 'SO:0000147']
16504174	57	['Substitution mutations are indicated by black lines.']	(7083, 7135)	[]
16504174	58	['The insertion is indicated by an open triangle.']	(7136, 7183)	[]
16504174	59	['Figure 3\n\nPromoter/enhancer activity of the ESG1 gene and pseudogene.']	(7185, 7254)	['PR:000006847', 'SO:0000167', 'SO:0000165', 'SO:0000704', 'SO:0000336']
16504174	60	["DNA fragments of ~6 kbp isolated from the 5' flanking regions of the gene and PS were transferred into luciferase reporter plasmids."]	(7255, 7387)	['SO:0000028', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0000704', 'SO:0000336', 'SO:0000155']
16504174	61	['We introduced the reporter genes into undifferentiated ES cells (open columns), retinoic acid-treated ES cells (grey columns), and NIH3T3 cells (closed columns).']	(7388, 7549)	['CHEBI:26536', 'CHEBI:26536', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'SO:0000704']
16504174	62	['Data represent the averages and standard deviations of three independent experiments.']	(7550, 7635)	[]
16504174	63	['We also found that the two BAC clones contained another ESG1-like sequence (Figure 2A).']	(7637, 7724)	['PR:000006847', 'SO:0000153']
16504174	64	['The two sequences, separated by a 68 kbp intergenic sequence, were oriented in opposite directions.']	(7725, 7824)	['SO:0000028', 'SO:0000605', 'SO:0000605']
16504174	65	['The ESG1-like sequence exhibited greater than 95% identity to the exons and introns of the ESG1 gene.']	(7825, 7926)	['PR:000006847', 'PR:000006847', 'SO:0000147', 'SO:0000188', 'SO:0000704']
16504174	66	['This sequence, however, contained critical nucleotide substitutions in all of the exons and one nucleotide insertion in exon 2 (Figure 2B).']	(7927, 8066)	['SO:0000147', 'SO:0000147']
16504174	67	["Although 675 base pairs of the 3' flanking regions were conserved between the ESG1 gene and the pseudogene, only five base pairs of the 5' flanking region were identical."]	(8067, 8237)	['PR:000006847', 'SO:0000028', 'SO:0000028', 'SO:0001417', 'SO:0001417', 'SO:0001417', 'SO:0001417', 'SO:0000704', 'SO:0000336', 'SO:0000028', 'SO:0000028', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416']
16504174	68	["This 5' flanking region (~6 kbp) did not possess any promoter/enhancer activity in luciferase reporter assays (Figure 3)."]	(8238, 8359)	['SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0000028', 'SO:0000167', 'SO:0000165']
16504174	69	['It is thus unlikely that this sequence is transcribed or translated into a functional protein.']	(8360, 8454)	['GO:0006412']
16504174	70	['This sequence likely represents a duplication pseudogene.']	(8455, 8512)	['SO:0000336']
16504174	71	['Bierbaum previously reported the existence of two pseudogenes with similar exon-intron organization as the ESG1 gene [17].']	(8513, 8635)	['PR:000006847', 'SO:0000336', 'SO:0000147', 'SO:0000188', 'SO:0000704']
16504174	72	['We could not determine which of these two pseudogenes corresponds to the one we identified or the location of the remaining pseudogene.']	(8636, 8771)	['SO:0000336', 'SO:0000336']
16504174	73	['Targeted disruption of the mouse ESG1 gene\n\nTo study the function of ESG1, we deleted the gene by homologous recombination in mouse ES cells.']	(8773, 8914)	['CL:0002322', 'CL:0002322', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'SO:0000704', 'SO:0000704']
16504174	74	['We replaced the three exons with either a fusion of the neomycin-resistance and β-galactosidase genes (β-geo) or the hygromycin resistant gene (HygR) using two targeting vectors (Figure 4A) introduced into RF8 ES cells by electroporation.']	(8915, 9153)	['CHEBI:7507', 'CHEBI:24753', 'CL:0002322', 'CL:0002322', 'SO:0000147', 'SO:0000704', 'SO:0000704', 'SO:0001644', 'SO:0001644']
16504174	75	['We obtained eight ES cell clones with correct homologous recombination of the β-geo targeting vector, which was confirmed by Southern blot analysis (Figure 4B).']	(9154, 9314)	['CL:0002322', 'CL:0002322', 'SO:0001644', 'SO:0001644']
16504174	76	['We obtained only one clone with correct homologous recombination of the HygR targeting vector.']	(9315, 9409)	['SO:0001644', 'SO:0001644']
16504174	77	['Figure 4\n\nTargeted disruption of the mouse ESG1 gene.']	(9411, 9464)	['NCBITaxon:10088', 'PR:000006847', 'SO:0000704']
16504174	78	['A) Targeting strategy.']	(9465, 9487)	[]
16504174	79	['Homologous regions are indicated by thick lines.']	(9488, 9536)	[]
16504174	80	['Recognition sites of PstI (P) and SpeI (S), which were used for Southern blot analyses, are shown.']	(9537, 9635)	['SO:0000409', 'SO:0000409']
16504174	81	["The gene encoding diphtheria toxin A (DTA) was inserted at the 3' end of the targeting vectors to facilitate negative selection."]	(9636, 9764)	['CHEBI:27026', 'SO:0000704', 'SO:0001644', 'SO:0001644']
16504174	82	['B) Southern blot analyses confirming homologous recombination.']	(9765, 9827)	[]
16504174	83	['WT, wild-type ES cells; β, β-geo +/- ES cells; H, HygR +/- ES cells; -/-, ESG1-null ES cells.']	(9828, 9921)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	84	['Numbers indicate clone numbers.']	(9922, 9953)	[]
16504174	85	['C) Northern blot (upper) and western blot (lower) analyses of wild-type ES cells (WT), ESG1-null ES cells (-/-, three clones) and heterozygous ES cells (+/-).']	(9954, 10112)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	86	['Northern blot was performed as previously described [20].']	(10113, 10170)	[]
16504174	87	['To confirm the loading of equal amounts of RNA, ethidium bromide staining of ribosomal RNA is also shown (middle).']	(10171, 10285)	['CHEBI:4883', 'CHEBI:4883', 'GO:0005840']
16504174	88	['To obtain homozygous mutant ES cells, we introduced the β-geo vector into HygR heterozygous ES cells.']	(10287, 10388)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'SO:0000440']
16504174	89	['Of 105 G418-resistant colonies tested, 49 were homozygous for ESG1 deletion.']	(10389, 10465)	['CHEBI:42768', 'PR:000006847']
16504174	90	['Northern blot and western blot analyses confirmed the absence of ESG1 in these cells (Figure 4C).']	(10466, 10563)	['PR:000006847']
16504174	91	['In 29 clones, the β-geo vector had replaced the HygR vector, such that the cells remained heterozygous.']	(10564, 10667)	['SO:0000440', 'SO:0000440']
16504174	92	['In the remaining 27 clones, the β-geo vector was integrated at non-homologous sites.']	(10668, 10752)	['SO:0000440']
16504174	93	['ESG1-/- ES cells exhibited normal morphology (Figure 5A).']	(10754, 10811)	['CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	94	['These cells also proliferated at a speed comparable to that of the control (heterozygous and wild-type) cells (Figure 5B).']	(10812, 10934)	['GO:0008283']
16504174	95	['ESG1-/- cells differentiated normally after the removal of leukemia inhibitory factor (Figure 5B) or retinoic acid treatment (not shown).']	(10935, 11072)	['CHEBI:26536', 'CHEBI:26536', 'PR:000006847', 'PR:000009799', 'PR:000009799', 'PR:000009799']
16504174	96	['When transplanted into hind flanks of nude mice, these cells produced teratomas, tumors containing components of all three germ layers (Figure 5C).']	(11073, 11220)	['NCBITaxon:10088', 'UBERON:0000180', 'UBERON:0000923', 'UBERON:0000923']
16504174	97	['These results indicate that ESG1 is dispensable for the self-renewal properties and pluripotency of ES cells.']	(11221, 11330)	['CL:0002322', 'CL:0002322', 'GO:0017145', 'GO:0017145', 'GO:0017145', 'PR:000006847']
16504174	98	['Figure 5\n\nAnalyses of ESG1-null ES cells.']	(11332, 11373)	['CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	99	['A) The morphology of ESG1-null ES cell colonies grown on STO feeder cells.']	(11374, 11448)	['CL:0002322', 'CL:0002322', 'GO:0040007', 'PR:000006847']
16504174	100	['B) Growth curve of wild-type (WT), ESG1-null (-/-) and heterozygous (+/-) ES cells.']	(11449, 11532)	['CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	101	['Each clone (1 × 104 cells/well) was plated in 24-well plates.']	(11533, 11594)	[]
16504174	102	['Cell numbers were determined with a Coulter counter at 2, 4, and 6 days.']	(11595, 11667)	[]
16504174	103	['Data of +/- and -/- cells are shown as averages and standard deviations of three independent clones.']	(11668, 11768)	[]
16504174	104	['C) A section of teratoma derived from ESG1-null ES cells (hematoxylin & eosin staining).']	(11769, 11857)	['CHEBI:51686', 'CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	105	['We examined the gene expression profiles of ESG1-/- ES cells using oligonucleotide-based DNA microarrays representing ~20,000 genes.']	(11859, 11991)	['CL:0002322', 'CL:0002322', 'GO:0010467', 'GO:0010467', 'PR:000006847', 'SO:0000704', 'SO:0000704']
16504174	106	['In comparison to control ES cells, ESG1 was identified as the gene reduced to the greatest extent in ESG1-/- ES cells (Figure 6A).']	(11992, 12122)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'PR:000006847', 'PR:000006847', 'SO:0000704']
16504174	107	['The expression of ES cell marker genes, such as Nanog and Oct3/4, was normal in ESG1-/- ES cells.']	(12123, 12220)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'GO:0010467', 'PR:000010968', 'PR:000013044', 'PR:000006847', 'SO:0000704']
16504174	108	['We confirmed normal Oct3/4 expression at protein levels by Western blot (Figure 6B).']	(12221, 12305)	['GO:0010467', 'PR:000013044']
16504174	109	['The overall gene expression profiles were similar between control ES cells and ESG1-/- ES cells.']	(12306, 12402)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'GO:0010467', 'GO:0010467', 'PR:000006847', 'SO:0000704']
16504174	110	['Several genes exhibited a greater than two-fold reduction in ESG1-/- cells, including Krt1-8, Pem, Ctgf, Ptgs2, Igf2 and Inhba.']	(12403, 12530)	['PR:000006847', 'PR:000009450', 'PR:000014397', 'PR:000003172', 'PR:000013428', 'PR:000000216', 'SO:0000704']
16504174	111	['These genes might be regulated directly or indirectly by ESG1.']	(12531, 12593)	['GO:0065007', 'PR:000006847', 'SO:0000704']
16504174	112	['Since ESG1 contains a KH-type RNA-binding domain, it may stabilize mRNA of these genes.']	(12594, 12681)	['PR:000006847', 'SO:0000417', 'SO:0000704']
16504174	113	['Further studied are required to clarify this possibility.']	(12682, 12739)	[]
16504174	114	['Figure 6\n\nGene expression analyses of ESG1-null ES cells.']	(12741, 12798)	['CL:0002322', 'CL:0002322', 'GO:0010467', 'GO:0010467', 'PR:000006847', 'SO:0000704']
16504174	115	['A) DNA microarray analyses.']	(12799, 12826)	[]
16504174	116	['Total RNA from wild-type ES cells and ESG1-null ES cells were labeled with Cy3 and Cy5, respectively.']	(12827, 12928)	['CHEBI:37987', 'CHEBI:37989', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	117	['Samples were hybridized to Agilent Mouse Developmental Microarrays.']	(12929, 12996)	['GO:0097617', 'NCBITaxon:10088']
16504174	118	['The averages of two independent clones are shown.']	(12997, 13046)	[]
16504174	119	['B) Western blot analyses.']	(13047, 13072)	[]
16504174	120	['Cell lysates from ESG1+/- and ESG1-/- cells were examined for expression of ESG1, Oct3/4 and CDK4 with immunoblotting.']	(13073, 13191)	['GO:0010467', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000013044', 'PR:000005257']
16504174	121	['To generate ESG1-knockout mice, we injected β-geo-ESG1+/- ES cell clones into the blastocysts of C57BL6 mice.']	(13193, 13302)	['CL:0002322', 'CL:0002322', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'UBERON:0000358']
16504174	122	['We obtained germline transmission from three clones.']	(13303, 13355)	[]
16504174	123	['We obtained ESG1-/- mice at the Mendelian ratios (36 wild-type, 69 ESG1+/-, and 45 ESG1-/-) from intercrosses of ESG1+/- mice.']	(13356, 13482)	['NCBITaxon:10088', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847']
16504174	124	['These animals exhibited normal development, gross appearance, and fertility (not shown).']	(13483, 13571)	['NCBITaxon:33208']
16504174	125	['Histological examination of testis and ovary could not identify any abnormalities (not shown).']	(13572, 13666)	['UBERON:0000473', 'UBERON:0000992']
16504174	126	['These data demonstrated that ESG1 is dispensable for both mouse development and germ cell formation.']	(13667, 13767)	['CL:0000586', 'CL:0000586', 'GO:0007281', 'GO:0007281', 'GO:0007281', 'NCBITaxon:10088', 'PR:000006847']
16504174	127	['We also generated ES cells from blastocysts obtained by intercrosses of ESG1+/- males and ESG1-/- females.']	(13769, 13875)	['CL:0002322', 'CL:0002322', 'PR:000006847', 'PR:000006847', 'UBERON:0000358']
16504174	128	['Of the eight ES cell lines established, two clones were ESG1-/-.']	(13876, 13940)	['CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	129	['These ESG1-null ES cells demonstrated normal morphology, proliferation, and differentiation (not shown), confirming that ESG1 is dispensable in ES cells.']	(13941, 14094)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'GO:0008283', 'PR:000006847', 'PR:000006847']
16504174	130	['Conclusion\n\nTo analyze the physiological roles of ESG1, we identified the mouse gene on chromosome 9 and deleted it by homologous recombination in ES cells.']	(14096, 14252)	['CL:0002322', 'CL:0002322', 'NCBITaxon:10088', 'PR:000006847', 'SO:0000704']
16504174	131	['Despite specific expression in early embryos, germ cells, and pluripotent cells, our data demonstrated that ESG1 is dispensable for mouse development, germ cell formation, and ES cell self-renewal.']	(14253, 14450)	['CL:0000586', 'CL:0000586', 'CL:0000586', 'CL:0000586', 'CL:0002322', 'CL:0002322', 'GO:0010467', 'GO:0007281', 'GO:0007281', 'GO:0007281', 'GO:0017145', 'GO:0017145', 'GO:0017145', 'GO:0017145', 'NCBITaxon:10088', 'PR:000006847', 'UBERON:0019248', 'UBERON:0019248']
16504174	132	["Methods\n\nIdentification and analyses of BAC clones containing the mouse ESG1 gene\n\nTo identify bacterial artificial chromosome (BAC) clones containing mouse ESG1 gene, we performed PCR-based screening of mouse BAC library DNA pools (Research Genetics) using the pH34-u38 (5'-GAAGTCTGGTTCCTTGGCAGG-3') and pH34-L394 (5'-ACTCGATACACTGGCCTAGC-3') primers."]	(14452, 14804)	['NCBITaxon:10088', 'NCBITaxon:2', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0000153', 'SO:0000704', 'SO:0000153', 'SO:0000153', 'SO:0000153', 'SO:0000153', 'SO:0000704', 'SO:0000153', 'SO:0000112']
16504174	133	["Following restriction enzyme digestion, we performed Southern blot analyses of BAC clones as described [20] using the pH34-U258 (5'-CTCGAGTGTACAGTCAAGTGGTTGCTGGGA-3'), pH34-U65 (5'-GTGACCCTCGTGACCCGTAA-3'), pH34-intron1L (5'-CTGCGTGAGAGAAACACCAAACAGGC-3'), pH34-L545 (5'-TGTGAATGGGAAGGTTACCACTCT-3') and pH34-SCL1 (5'-GCCCTCTTCTGGTTTGTCTCGAAAT-3') probes."]	(14805, 15160)	['PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0000153']
16504174	134	['Hybridization with these probes revealed bands containing either the ESG1 gene or pseudogenes.']	(15161, 15255)	['GO:0097617', 'PR:000006847', 'SO:0000704', 'SO:0000336']
16504174	135	["To sequence the region containing the mouse ESG1 gene and the 3' flanking region, we subcloned a ~15 kbp XhoI-SalI fragment into the pZERO-2 vector (Invitrogen)."]	(15257, 15418)	['NCBITaxon:10088', 'PR:000006847', 'SO:0000704', 'SO:0001417', 'SO:0001417', 'SO:0001417', 'SO:0001417', 'SO:0000028', 'SO:0000440']
16504174	136	['HindIII- or EcoRI-digested fragments of this vector were then cloned into pBluescript KS(-) for sequencing.']	(15419, 15526)	['PR:P43870', 'SO:0000440']
16504174	137	["To sequence the ESG1 pseudogene and the 3' flanking region, an 8 kbp NotI/XhoI fragment was cloned into pBluescript KS(-)."]	(15527, 15649)	['PR:000006847', 'SO:0000336', 'SO:0001417', 'SO:0001417', 'SO:0001417', 'SO:0001417', 'SO:0000028']
16504174	138	['BamHI- or PstI- fragments of this vector were also cloned into pBluescript KS(-).']	(15650, 15731)	['PR:P23940', 'SO:0000440']
16504174	139	["To identify the sequence containing the 5' flanking regions of the ESG1 gene and the related pseudogenes, we used a TOPO walker kit (Invitrogen) with the pH34-T2L (5'-ACTAGTCGCAGCAGGGATCCAGGAATATCT-3') and pH34-L394 primers."]	(15732, 15956)	['PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0000704', 'SO:0000336', 'SO:0000112']
16504174	140	['The resulting sequence was cloned into pCR2.1 (Invitrogen).']	(15957, 16016)	[]
16504174	141	['We obtained a ~6 kbp band from the NsiI-digensted library; XbaI-, SpeI-, EcoRI-, and PstI-digested fragments of this band were cloned into pBluescript KS(-) for sequencing.']	(16017, 16189)	['SO:0000028']
16504174	142	["This fragment contained the 5' flanking region of the ESG1 gene."]	(16190, 16254)	['PR:000006847', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0001416', 'SO:0000704']
16504174	143	['A ~3 kbp fragment, obtained from the SacI-digested library, was cloned into pCR2.1 for sequencing.']	(16255, 16353)	['SO:0000028']
16504174	144	["This fragment was contained the 5' region flanking the pseudogene."]	(16354, 16420)	['SO:0000357', 'SO:0000336']
16504174	145	['Construction of ESG1 targeting vectors\n\nWe replaced all of the ESG1 exons with two targeting vectors containing either an IRES-β-geo cassette [21] or an IRES-HygR cassette by promoter trap selection.']	(16422, 16621)	['PR:000006847', 'PR:000006847', 'SO:0001644', 'SO:0001644', 'SO:0000147', 'SO:0001644', 'SO:0001644', 'SO:0000243', 'SO:0005853', 'SO:0000243', 'SO:0005853', 'SO:0000167']
16504174	146	["We amplified the 5' arm (1.8 kbp) using KOD plus (TOYOBO) with the pH34-targetpair5-U (5'-CCGCGGAAAGTCAAGAGATTGGGTGG-3') and pH34-targetpair5-L (5'-GCGGCCGCCTTTACGGGTCACGAGGGTCAC-3') primers."]	(16622, 16813)	['PR:000006847', 'PR:000006847', 'SO:0000028', 'SO:0000112']
16504174	147	["The 3' arm (5.8 kbp) was amplified using the pH34-targetpair3-U (5'-TGTGGCCAGTGTTTGGTTCTGGCGGG-3') and pH34-targetpair3-L (5'-CTCGAGGACTCGCCATTCTAGCCAAG-3') primers."]	(16814, 16979)	['PR:000006847', 'PR:000006847', 'SO:0000028', 'SO:0000112']
16504174	148	['The IRES β-geo or IRES HygR cassettes were ligated in between the two PCR fragments.']	(16980, 17064)	['GO:0006266', 'SO:0000243', 'SO:0000243', 'SO:0005853']
16504174	149	["The diphtheria toxin A cassette was placed downstream of the 3' arm."]	(17065, 17133)	['CHEBI:27026', 'SO:0005853']
16504174	150	['After linearization with SacII, these targeting vectors were electroporated into 2.0 × 107 RF8 ES cells [22] using a Gene pulser (BIORAD).']	(17134, 17272)	['CL:0002322', 'CL:0002322', 'SO:0001644', 'SO:0001644', 'SO:0000704']
16504174	151	['Transfected cells were selected with 250 μg/mL G418 or 100 μg/mL hygromycin B, respectively.']	(17273, 17365)	['CHEBI:42768', 'CHEBI:16976', 'CHEBI:16976', 'GO:0009294']
16504174	152	['Genomic DNA from G418- or hygromycin B-resistant colonies was screened for homologous recombination by Southern blotting.']	(17366, 17487)	['CHEBI:42768', 'CHEBI:16976', 'CHEBI:16976', 'SO:0001026']
16504174	153	['Southern blot screening for homologous recombination\n\nES cells genomic DNA was extracted with PUREGENE™ Cell Lysis Solution (Gentra systems).']	(17489, 17630)	['CHEBI:75958', 'CL:0002322', 'CL:0002322', 'GO:0019835', 'GO:0019835', 'SO:0001026']
16504174	154	["For 5' Southern blot analysis, genomic DNA was first digested with PstI, then separated on an 0.8% agarose gel and transferred to a nylon membrane as described [20]."]	(17631, 17796)	['CHEBI:2511', 'CHEBI:25614', 'SO:0001026']
16504174	155	["A 560 bp 5' probe was amplified using the ESG1S5 (5'- GATGGTGGTGGTGACTCAGAG -3') and ESG1AS5 as (5'- CCTCCATTGCCTCTATATCAG -3') primers."]	(17797, 17933)	['SO:0000028', 'SO:0000112']
16504174	156	['The probe specifically labeled an 18 kbp band from the wild-type locus, a 15 kbp band from the β-geo locus, and a 12 kbp band from the HygR locus.']	(17934, 18080)	['SO:0000028', 'SO:0000028', 'SO:0000028']
16504174	157	["Genomic DNA was also digested with SpeI for 3' Southern blot analysis."]	(18081, 18151)	['SO:0001026']
16504174	158	["A 1,010 bp 3' probe was amplified with the pH34U-8000 (5'- CCAACCAGCCAGAGTTTCAGTTAT -3') and pH34L-9000 (5'-GATAAGCTGCTGCCAAAAGACAAG -3') primers."]	(18152, 18298)	['SO:0000028', 'SO:0000112']
16504174	159	['The probe hybridized to an 11.5 kbp band from the wild-type locus, a 12.5 kbp band from the β-geo locus, and a 9.5 kbp band from the HygR locus.']	(18299, 18443)	['GO:0097617', 'SO:0000028', 'SO:0000028', 'SO:0000028']
16504174	160	["Generation of anti-ESG1 polyclonal antibodies\n\nThe coding sequence of Esg1 was amplified by PCR with the pH34-gw-s (5'- AAAAAGCAGGCTGGATGATGGTGACCCTCGTGA-3') and pH34-gw-as (5'- AGAAAGCTGGGTCTGCATCCAGGTCGGAGACA-3') primers."]	(18445, 18668)	['GO:0042571', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'SO:0000112']
16504174	161	['To construct pDONR-pH34, the resulting PCR product was subcloned into pDONR201 (Invitrogen).']	(18669, 18761)	['PR:000006847', 'SO:0000006', 'SO:0000006']
16504174	162	['pDONR-pH34 was interacted with pDEST17 (Invitrogen) by LR recombination.']	(18762, 18834)	['PR:000006847']
16504174	163	["After introduction of the resulting expression vector pDEST17-pH34 into BL21-AI E. coli (Invitrogen), recombinant protein production was induced according to the manufacture's protocol."]	(18835, 19020)	['GO:0010467', 'GO:0006412', 'GO:0006412', 'NCBITaxon:562', 'NCBITaxon:562', 'NCBITaxon:562', 'PR:000006847', 'SO:0000440']
16504174	164	['Histidine-tagged ESG1 was purified using Ni-nitrilotriacetic acid agarose (Qiagen) under denaturing conditions in the presence of 8 M urea.']	(19021, 19160)	['CHEBI:44557', 'CHEBI:44557', 'CHEBI:2511', 'CHEBI:16199', 'PR:000006847']
16504174	165	['After dialysis against 6 M urea, the recombinant proteins were injected into New Zealand White rabbits to generate anti-ESG1 polyclonal antibodies.']	(19161, 19308)	['CHEBI:16199', 'GO:0042571', 'NCBITaxon:9986', 'PR:000006847']
16504174	166	['Western blot\n\nAfter preparation of ES cell extracts with M-Per (Pierce), cellular proteins were separated on sodium dodecyl sulfate (SDS)-14% polyacrylamide gels and transferred to nitrocellulose membranes (Millipore).']	(19310, 19528)	['CHEBI:8984', 'CHEBI:8984', 'CHEBI:8984', 'CHEBI:8984', 'CHEBI:53325', 'CL:0002322', 'CL:0002322']
16504174	167	['Membranes were incubated with anti-ESG1 (1/500 dilution), anti-Oct3/4 (1/500; Santa Cruz Biotechnology), anti-CDK4 (1/200; Santa Cruz Biotechnology), and anti-GFP (1/1000; MBL) primary antibodies.']	(19529, 19725)	['GO:0042571', 'PR:000006847', 'PR:000013044', 'PR:000005257']
16504174	168	['Horseradish peroxidase-conjugated anti-rabbit and anti-mouse immunoglobulins (1/5000; Cell Signaling) were used to detect antibody binding.']	(19726, 19865)	['GO:0019814', 'GO:0042571', 'MOP:0000779', 'NCBITaxon:3704', 'NCBITaxon:9986', 'NCBITaxon:10088']
16504174	169	['We visualized bound antibody with an ECL Western Blotting Detection System (Amersham).']	(19866, 19952)	['GO:0042571']
16504174	170	['Derivation of ESG1-deficient ES cells from blastocysts\n\nEsg1+/-or ESG1-/- mutant female mice were injected with Tamoxifen (10 μg) and Depo-provera (1 mg) subcutaneously on the third day of pregnancy.']	(19954, 20153)	['CHEBI:41774', 'CHEBI:6716', 'CHEBI:6716', 'CHEBI:6716', 'CL:0002322', 'CL:0002322', 'GO:0007565', 'NCBITaxon:10088', 'PR:000006847', 'PR:000006847', 'PR:000006847', 'UBERON:0000358']
16504174	171	["Four days later, embryos in diapause were flushed out of the uterus and cultured on STO feeder cells in four-well plates in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 20% Fetal Bovine Serum (Hyclone), 0.1 mM Non-Essential Amino Acids (Invitrogen), 2 mM L-glutamine (Invitrogen), 50 U/ml Penicillin-Streptomysin (Invitrogen), and 0.11 mM 2-mercaptoethanol (Invitrogen)."]	(20154, 20537)	['CHEBI:17334', 'CHEBI:17076', 'CHEBI:41218', 'CHEBI:41218', 'CHEBI:41218', 'NCBITaxon:27592', 'UBERON:0000922', 'UBERON:0000995', 'UBERON:0001977']
16504174	172	['After six days, the central mass of each explant was harvested, rinsed in PBS, and placed in a drop of trypsin for a few minutes.']	(20538, 20667)	['PR:000027795']
16504174	173	['The cell mass was collected with a finely drawn-out Pasteur pipette preloaded with medium, ensuring minimal carryover of the trypsin.']	(20668, 20801)	['PR:000027795']
16504174	174	['The cells were gently transfered into a fresh well with 20% FBS-containing medium.']	(20802, 20884)	[]
16504174	175	['The resulting primary ES cell colonies were individually passaged into wells of four-well plates containing STO feeder cell layers.']	(20885, 21016)	['CL:0000001', 'CL:0002322', 'CL:0002322', 'CL:0000001', 'UBERON:0000119', 'UBERON:0000119']
16504174	176	['Thereafter, cells were expanded by trypsinization of the entire culture.']	(21017, 21089)	[]
16504174	177	['Microarrays\n\nTotal RNA from wild-type ES cells and ESG1-/- ES cells was labeled with Cy3 and Cy5, respectively.']	(21091, 21202)	['CHEBI:37987', 'CHEBI:37989', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'PR:000006847']
16504174	178	["The samples were hybridized to a Mouse Development Microarray (Algilent) according to the manufacturer's protocol."]	(21203, 21317)	['GO:0097617', 'NCBITaxon:10088']
16504174	179	['Arrays were scanned with a G2565BA Microarray Scanner System (Agilent).']	(21318, 21389)	[]
16504174	180	['Hybridization was repeated with two independent clones.']	(21390, 21445)	['GO:0097617']
16504174	181	['Data were analyzed with GeneSprings software (Silico Genetics).']	(21446, 21509)	[]
16504174	182	["Authors' contributions\n\nHA carried out the phenotypic studies of ESG1 knockout mice."]	(21511, 21595)	['NCBITaxon:10088', 'PR:000006847']
16504174	183	['KI determined the chromosomal localizations of the ESG1 gene and pseudogenes and constructed the targeting vector.']	(21596, 21710)	['PR:000006847', 'SO:0000704', 'SO:0000336', 'SO:0001644', 'SO:0001644']
16504174	184	['TI carried out mouse embryo manipulation.']	(21711, 21752)	['NCBITaxon:10088', 'UBERON:0000922']
16504174	185	['MM and MN carried out ES cell culture.']	(21753, 21791)	['CL:0002322', 'CL:0002322']
16504174	186	['SY conceived of the study, and participated in its design and coordination and helped to draft the manuscript.']	(21792, 21902)	[]
16504174	187	['All authors read and approved the final manuscript.']	(21903, 21954)	[]
16504174	188	['Acknowledgements\n\nWe thank Chihiro Takigawa, Junko Iida, Masako Shirasaka, Yumi Ohuchi, and Megumi Narita for their technical and administrative assistance.']	(21956, 22112)	[]
16504174	189	['We are grateful to Drs.']	(22113, 22136)	[]
16504174	190	['Minoru Ko and Azim Surani for sharing helpful data prior to publication, Dr. Hitoshi Niwa for generously providing various vectors, and Dr. Robert Farese Jr. for his kind gift of the RF8 ES cells.']	(22137, 22333)	['CL:0002322', 'CL:0002322', 'SO:0000440']
16504174	191	['This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Uehara Memorial Foundation, the Naito Foundation, the Sumitomo Research Foundation, the Mitsubishi Foundation.']	(22334, 22582)	[]
16504174	192	['S.Y.']	(22583, 22587)	[]
16504174	193	['was supported by a Toray Science and Technology Grant (to S.Y.).']	(22588, 22652)	[]
16504174	194	['This work was also supported in part by a Grant-in-Aid for 21st Century COE (Center of Excellence) Research from the Ministry of Education, Culture, Sports, Science, and Technology.']	(22653, 22834)	[]
